2-(5-(Bromomethyl)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1-[3-(Chloromethyl)-4-methoxyphenyl]ethanone, 97.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methyl-1H-indol-3-yl)propanoic acid, 95%, 5g

3-ETHOXY-2,2-DIMETHYLCYCLOBUTANONE, 95.0%, 1g

N,N-Dimethyl-1-(piperidin-4-yl)methanamine dihydrochloride, 95.0%, 5g

4-(Methylsulfonyl)benzoic acid, 98.0%, 1g

4-Methyl-6-nitro-1H-indazole, 95.0%, 250mg

1-(2-Fluoro-[1,1'-biphenyl]-4-yl)ethan-1-one, 97%, 250mg

2,4-Dichloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98%, 100mg

tert-Butyl (3S)-3-hydroxy-2,2-dimethyl-azetidine-1-carboxylate, 98%, 250mg

5-Bromo-2,4-dichloro-6-(trifluoromethyl)pyrimidine, 95.0%, 1g

Écran de protection SEKUROKA® avec plaques latérales Type 750, 1 pièce

2-Isopropoxyaniline, 95.0%, 25g